All Pharma News
Freeline Presents Gaucher, Parkinson`s Data at ASGCT Annual Meeting

Freeline Presents Gaucher, Parkinson`s Data at ASGCT Annual Meeting
GLOBENEWSWIRE
24 Apr 2024
Share Share
Acquisition of Freeline by Syncona Becomes Effective

Acquisition of Freeline by Syncona Becomes Effective
GLOBENEWSWIRE
20 Feb 2024
Share Share
Freeline Shareholders Approve Acquisition by Syncona

Freeline Shareholders Approve Acquisition by Syncona
GLOBENEWSWIRE
12 Feb 2024
Share Share
Syncona to Acquire Freeline Therapeutics

Syncona to Acquire Freeline Therapeutics
GLOBENEWSWIRE
22 Nov 2023
Share Share
Syncona throws lifeline to Freeline by buying struggling biotech

Syncona throws lifeline to Freeline by buying struggling biotech
James Waldron FIERCE BIOTECH
22 Nov 2023
Share Share
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201

Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201
GLOBENEWSWIRE
25 Oct 2023
Share Share
Freeline, facing fading cash runway, mulls buyout by Syncona

Freeline, facing fading cash runway, mulls buyout by Syncona
James Waldron FIERCE BIOTECH
19 Oct 2023
Share Share
Syncona eyes buyout of gene therapy biotech Freeline

Syncona eyes buyout of gene therapy biotech Freeline
Ayisha Sharma ENDPTS
18 Oct 2023
Share Share
Freeline to Present New Data for FLT201 in Gaucher Disease in Presentation

Freeline to Present New Data for FLT201 in Gaucher Disease in Presentation
GLOBENEWSWIRE
16 Oct 2023
Share Share
Freeline Reports Positive Data from Phase 1/2 GALILEO-1 Trial of FLT201

Freeline Reports Positive Data from Phase 1/2 GALILEO-1 Trial of FLT201
GLOBENEWSWIRE
04 Oct 2023
Share Share